Noveris Health Sciences Inc. will release its second-quarter 2026 financial results on Sunday, August 9, 2026.
The upcoming report follows a period of significant volatility in the company's stock price.
Management issued a statement on August 6, 2026, in response to a request from the Canadian Investment Regulatory Organization (CIRO). The company confirmed it was unaware of any material operational changes that would account for the recent spike in trading activity.
This earnings release represents the first major financial disclosure since the CIRO inquiry.